Skip to content

INTEGRATED WELLNESS ACQUISITION CORP: 10-Q filed 2025-11-25

What INTEGRATED WELLNESS ACQUISITION CORP reported in its quarterly report filed 2025-11-25 (fiscal Q3 2025): 17 published measures, 54 facts as tagged in accession 0001104659-25-116051.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-25
Fiscal period
fiscal Q3 2025
Accession
0001104659-25-116051 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTEGRATED WELLNESS ACQUISITION CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3015,047,245USD
At 2024-12-3114,221,800USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3012,696,752USD
At 2024-12-3111,341,823USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-30-12,694,147USD
At 2025-06-30-12,142,095USD
At 2025-03-31-11,871,058USD
At 2024-12-31-11,335,340USD
At 2024-09-30-10,766,259USD
At 2024-06-30-9,863,059USD
At 2024-03-31-8,915,954USD
At 2023-12-31-8,125,340USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-300USD
At 2024-12-315,141USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-302,631USD92
2025-01-01 to 2025-09-30-619,485USD273
2025-04-01 to 2025-06-30-24,353USD91
2025-01-01 to 2025-03-31-292,501USD90
2024-07-01 to 2024-09-30-24,472USD92
2024-01-01 to 2024-09-30-139,980USD274
2024-04-01 to 2024-06-30-78,378USD91
2024-01-01 to 2024-03-31-37,130USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-3081,346USD273
2024-01-01 to 2024-09-30895,468USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30742,836USD273
2024-01-01 to 2024-09-301,933,233USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-12,694,435USD
At 2024-12-31-11,335,628USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-420,952USD92
2025-01-01 to 2025-09-30-966,974USD273
2024-07-01 to 2024-09-30-558,200USD92
2024-01-01 to 2024-09-30-1,720,919USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-302,605USD
At 2024-12-316,482USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-308,671,752USD
At 2024-12-317,316,823USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-30480,483USD
At 2024-12-31416,320USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-30420,952USD92
2025-01-01 to 2025-09-30966,974USD273
2024-07-01 to 2024-09-30558,200USD92
2024-01-01 to 2024-09-301,720,919USD274

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-3015,044,640USD
At 2024-12-3114,220,458USD
At 2024-09-3050,302,879USD
At 2023-12-3147,474,178USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-09-302,491,816USD
At 2024-12-311,943,887USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-619,485USD273
2024-01-01 to 2024-09-30-139,980USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-30118,321USD92
2025-01-01 to 2025-09-30347,489USD273
2024-07-01 to 2024-09-30533,728USD92
2024-01-01 to 2024-09-301,580,939USD274

Inspect the source

Entity
INTEGRATED WELLNESS ACQUISITION CORP / CIK 0001877557
Captured
2026-09-21T17:22:48.332Z
SEC response SHA-256
dfe57a6edc44981efe44aa36b78f48e7760d654a84769e85034de9a2e06d41e4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001877557.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))